Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, AIM Vaccine Co's Enterprise Value is HK$4,107 Mil.
AIM Vaccine Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was HK$-61 Mil. Therefore, AIM Vaccine Co's EV-to-FCF for today is -67.33.
The historical rank and industry rank for AIM Vaccine Co's EV-to-FCF or its related term are showing as below:
HKSE:06660'
s EV-to-FCF Range Over the Past 10 Years
Min: -67.73 Med: -28.24 Max: -9.03
Current: -67.33
During the past 7 years, the highest EV-to-FCF of AIM Vaccine Co was -9.03. The lowest was -67.73. And the median was -28.24.
HKSE:06660's EV-to-FCF is ranked worse than 100% of 314
companies
in the Biotechnology industry
Industry Median: 14.775
vs HKSE:06660: -67.33
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
AIM Vaccine Co's PE Ratio (TTM) for today is calculated as:
AIM Vaccine Co's share price for today is HK$1.675.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AIM Vaccine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was HK$-0.602.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
AIM Vaccine Co EV-to-FCF Related Terms
AIM Vaccine Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for AIM Vaccine Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:06660 vs VRTX, REGN, MRNA: EV-to-FCF Comparison
For the Biotechnology subindustry, AIM Vaccine Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AIM Vaccine Co EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, AIM Vaccine Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where AIM Vaccine Co's EV-to-FCF falls into.
AIM Vaccine Co's current Enterprise Value is HK$4,107 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AIM Vaccine Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was HK$-61 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AIM Vaccine Co (HKSE:06660) has a EV-to-FCF of -67.33 as of Sep. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on AIM Vaccine Co and its competitors. According to the industry distribution chart, AIM Vaccine Co ranks #999999 out of 314 companies in the Biotechnology industry.
Is AIM Vaccine Co's EV-to-FCF too high?
AIM Vaccine Co's current EV-to-FCF is -67.33. Based on the distribution chart, AIM Vaccine Co ranks #999999 out of 314 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, AIM Vaccine Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AIM Vaccine Co's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, AIM Vaccine Co ranks #999999 out of 314 companies for EV-to-FCF. This places AIM Vaccine Co in the lower half of its industry. The industry median EV-to-FCF is 14.78. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 14.78, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on AIM Vaccine Co and its competitors. For the Biotechnology industry, the median EV-to-FCF is 14.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AIM Vaccine Co's current EV-to-FCF is -67.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AIM Vaccine Co stock overvalued right now?
Based on GuruFocus' analysis, AIM Vaccine Co (HKSE:06660) is currently considered Possible Value Trap. The stock's GF Value™ is HK$4.08, compared to a current price of HK$1.68 — trading 58.9% below its estimated fair value. The current EV-to-FCF is -67.33. AIM Vaccine Co's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For AIM Vaccine Co (HKSE:06660), the current EV-to-FCF is -67.33 as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AIM Vaccine Co (HKSE:06660) Overvalued in 2026?
Based on GuruFocus' analysis, AIM Vaccine Co stock appears to be undervalued.
The current stock price of HK$1.68 is trading 58.9% below its estimated GF Value™ of HK$4.08.
GuruFocus considers AIM Vaccine Co to be Possible Value Trap.
Key valuation signals for HKSE:06660:
EV-to-FCF: -67.33
GF Value™: HK$4.08 vs. price of HK$1.68 (58.9% below fair value)
No single metric tells the full story. See the HKSE:06660 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AIM Vaccine Co Ltd is a China-based full-chain vaccine company engaged in the research and development, manufacturing, and commercialization of vaccine products. The company's commercialized products include recombinant HBV vaccines, freeze-dried human rabies vaccines, inactivated HAV vaccines, Group A, C, Y, and W135 meningococcal polysaccharide vaccines, bivalent inactivated HFRS vaccines, and mumps vaccines. The company generates the majority of its revenue from the PRC.
61GF Score
Get the complete analysis for HKSE:06660
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06660 has been successfully added to your 
